McKesson Estimated Litigation Liability, Noncurrent decreased by 0.2% to $5.09B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.1%, from $5.60B to $5.09B. Over 5 years (FY 2021 to FY 2026), Estimated Litigation Liability, Noncurrent shows a downward trend with a -8.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase signals higher expected legal costs or adverse developments in ongoing litigation.
This represents the estimated liability for legal proceedings and settlements that are expected to be resolved beyond th...
Highly relevant for McKesson, Cencora, and Cardinal Health due to shared industry-wide litigation risks.
other_litigation_reserve_noncurrent| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.60B | $7.15B | $7.15B | $7.22B | $7.13B | $6.64B | $6.64B | $6.63B | $6.63B | $6.13B | $6.13B | $6.11B | $6.11B | $5.62B | $5.62B | $5.60B | $5.60B | $5.10B | $5.10B | $5.09B |
| QoQ Change | — | -5.9% | +0.1% | +0.9% | -1.2% | -6.8% | -0.0% | -0.3% | +0.0% | -7.5% | +0.0% | -0.2% | +0.0% | -8.1% | +0.0% | -0.3% | +0.0% | -8.9% | +0.0% | -0.2% |
| YoY Change | — | — | — | — | -6.1% | -7.0% | -7.1% | -8.2% | -7.1% | -7.8% | -7.7% | -7.7% | -7.8% | -8.3% | -8.3% | -8.4% | -8.4% | -9.2% | -9.2% | -9.1% |